Cataract Surgery Device Enhancement Receives FDA Clearance

Article

Bausch and Lomb's Victus femtosecond laser platform has received clearance from the FDA for an enhanced patient interface kit.

Bausch and Lomb’s Victus femtosecond laser platform has received clearance from the FDA for an enhanced patient interface kit.

The Victus platform is indicated to create a corneal flap in patients undergoing cataract surgery. Its enhanced interface includes a small diameter suction clip, which allows it to open and close easier for better placement in patients with narrow fissures and smaller eye openings.

“The smaller profile in the enhanced patient interface…will allow surgeons to have even greater control and ease of use in patients with narrow fissures, further supporting improved suction and better overall comfort,” stated Jeffrey Whitman, president and chief surgeon at the Key-Whitman Eye Center in Dallas, Texas.

Additional features of the interface kit include a colored suction skirt, multi-port suction design, and ergonomical design, all of which assist surgeons throughout the eye procedure.

“We are very pleased to provide this advancement to our Victus femtosecond laser to surgeons and their patients,” stated Ari Kellen, head of US Eye Health at Bausch and Lomb. “…We are committed to investing in the technology and surgical enhancements to meet the needs of doctors and their patients.”

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.